Allergan, Inc. News Headlines

AGN 
$189.44
*  
2.67
1.43%
Get AGN Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Valeant Hints at Higher Allergan Bid -- 4th Update
10/27/2014 9:34:00 AM - Dow Jones Business News


Allergan : Valeant's Letter Simply Tactic To Distract Investors From Q3 Results
10/27/2014 9:30:00 AM - RTT News


Futures Defensive on German Business Confidence, Brazil's Election, Upcoming Data and FOMC
10/27/2014 9:23:32 AM - MT Newswires


Valeant Hints at Higher Allergan Bid -- 3rd Update
10/27/2014 9:05:00 AM - Dow Jones Business News


Canadian Stocks Poised For Sluggish Open -- Canadian Commentary
10/27/2014 8:56:00 AM - RTT News


Valeant Hints at Higher Allergan Bid -- 2nd Update
10/27/2014 8:33:00 AM - Dow Jones Business News


Stock Market Today: Stock Futures Fall After Biggest Weekly Rally of 2014
10/27/2014 8:32:00 AM - TheStreet


Allergan Q3 Results Top View; Valeant Prepared To Raise Offer For Botox Maker
10/27/2014 8:26:00 AM - RTT News


Allergan (AGN) Stock Higher Today After Possible New Valeant Pharmaceuticals (VRX) Bid
10/27/2014 8:05:00 AM - TheStreet


Allergan Q3 14 Earnings Conference Call At 9:00 AM ET
10/27/2014 8:00:00 AM - RTT News


Allergan Q3 Profit Beats Estimates - Quick Facts
10/27/2014 7:19:00 AM - RTT News


Valeant :prepared To Improve For Allergan And Provide Value Of At Least $200/shr
10/27/2014 7:08:00 AM - RTT News


Week Ahead: 3 IPOs planned for the week of October 27 include boots, breast implants and pipelines
10/26/2014 5:27:10 PM - Renaissance Capital


ETF Preview: Broad Market ETFs Decline in Line With Futures; Earnings in Focus
10/24/2014 1:23:05 PM - MT Newswires


J&J and Glaxo Ready to Collaborate for Ebola Vaccine Work - Analyst Blog
10/24/2014 10:51:00 AM - Zacks.com


Glaxo Gains on Q3 Earnings Beat and Restructuring Plans - Analyst Blog
10/24/2014 9:35:00 AM - Zacks.com


Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated - Analyst Blog
10/22/2014 10:28:00 AM - Zacks.com


TSX Sustains Strength, Up 176 Points Mid-Afternoon, Still Driven by Resources, Healthcare
10/21/2014 2:25:08 PM - MT Newswires


TSX Stronger at Midday, Up More Than 1% at Day High; Industrials, Resources Best Performers
10/21/2014 12:22:01 PM - MT Newswires


Valeant Pharmaceuticals Makes Its Case With an Earnings Beat
10/21/2014 9:30:02 AM - Motley Fool


Digging Deeper Into Valeant's Organic Growth Claims
10/21/2014 7:14:00 AM - Seeking Alpha


Bloomberg: Actavis Among Final-stage Bidders For Omega Pharmaceuticals
10/20/2014 10:49:00 PM - RTT News


Medical Properties To Buy 40 Rehabilitation Hospitals In Germany For $900 Mln
10/20/2014 10:48:00 PM - RTT News


Can Valeant's Strong Q3 Entice Allergan?
10/20/2014 6:47:00 PM - Investor's Business Daily


Sanofi and Regeneron Dose Patients in Dupilumab Study - Analyst Blog
10/20/2014 5:45:00 PM - Zacks.com